09:54 AM EST - Helix BioPharma Corp. : Says it intends to file its interim consolidated financial statements for the three- and nine-month periods ended April 30, 2020, related management’s discussion and analysis and related management certifications by July 30, 2020. Helix BioPharma Corp.
shares T.HBP are trading unchanged at $0.63.
